Balance sheet components (Tables)

9 Months Ended

Sep. 30, 2026

Balance sheet components

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	September 30, 2026		December 31, 2025
Manufacturing expenses	$	12,326	$	9,462
Compensation and related benefits		10,241		11,527
Clinical development expenses		8,718		7,036
Operating lease liabilities, current portion		1,127		—
Development milestones		986		10,000
Other		3,107		3,626
Total accrued expenses and other current liabilities	$	36,505	$	41,651